McKesson Corporation Market Cap ($101.38 Billion)
Market Cap & Net Worth: McKesson Corporation (MCK)
McKesson Corporation market cap. McKesson Corporation (NYSE:MCK) has a market capitalization of $101.38 Billion ($101.38 Billion) as of November 5, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #249 globally and #130 in its home market, demonstrating a 0.68% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying McKesson Corporation's stock price $999.62 by its total outstanding shares 116590363 (116.59 Million). Also see MCK cash generation efficiency for how efficiently the company converts equity into cash flow.
McKesson Corporation Market Cap History (2015–2026)
McKesson Corporation market cap history from 2015 to 2026. Data shows growth from $21.39 Billion to $116.55 Billion (16.73% CAGR). Check MCK share price today for real-time trading data and today's change.
Index Memberships
McKesson Corporation is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$61.76 Trillion | 0.19% | #104 of 503 |
Weight: McKesson Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
McKesson Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how McKesson Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore McKesson Corporation (MCK) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.29x
McKesson Corporation's market cap is 0.29 times its annual revenue
Latest Price to Earnings (P/E) Ratio
24.47x
McKesson Corporation's market cap is 24.47 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $17.17 Billion | $198.53 Billion | $5.18 Billion | 0.09x | 3.31x |
| 2018 | $12.29 Billion | $208.36 Billion | $67.00 Million | 0.06x | 183.43x |
| 2019 | $15.57 Billion | $214.32 Billion | $34.00 Million | 0.07x | 458.05x |
| 2020 | $19.79 Billion | $231.05 Billion | $900.00 Million | 0.09x | 21.99x |
| 2021 | $28.54 Billion | $238.23 Billion | -$4.54 Billion | 0.12x | N/A |
| 2022 | $43.33 Billion | $263.97 Billion | $1.11 Billion | 0.16x | 38.90x |
| 2023 | $53.79 Billion | $276.71 Billion | $3.56 Billion | 0.19x | 15.11x |
| 2024 | $66.45 Billion | $308.95 Billion | $3.00 Billion | 0.22x | 22.13x |
| 2025 | $95.64 Billion | $359.05 Billion | $3.29 Billion | 0.27x | 29.03x |
| 2026 | $116.55 Billion | $403.43 Billion | $4.76 Billion | 0.29x | 24.47x |
Competitor Companies of MCK by Market Capitalization
Companies near McKesson Corporation in the global market cap rankings as of November 5, 2026. Also see MCK current and non-current assets for a full breakdown of the balance sheet.
Key companies related to McKesson Corporation by market ranking:
- Cencora Inc. (NYSE:COR): Ranked #453 globally with a market cap of $61.32 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #624 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1124 globally with a market cap of $22.95 Billion USD ( AU$32.44 Billion AUD).
- Sigma Healthcare Limited (F:S5YA): Ranked #1265 globally with a market cap of $19.74 Billion USD ( €16.88 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #453 | Cencora Inc. | NYSE:COR | $61.32 Billion | $340.50 |
| #624 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $252.94 |
| #1124 | Sigma Healthcare Ltd | AU:SIG | $22.95 Billion | AU$2.81 |
| #1265 | Sigma Healthcare Limited | F:S5YA | $19.74 Billion | €1.71 |
Market Capitalization of McKesson Corporation (2015–2026)
Market capitalization of McKesson Corporation from 2015 to today. Between 2015 and today, McKesson Corporation's market cap moved from $21.39 Billion to $ 116.55 Billion, with a yearly change of 16.73%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $116.55 Billion | +21.86% |
| 2025 | $95.64 Billion | +43.93% |
| 2024 | $66.45 Billion | +23.53% |
| 2023 | $53.79 Billion | +24.13% |
| 2022 | $43.33 Billion | +51.83% |
| 2021 | $28.54 Billion | +44.23% |
| 2020 | $19.79 Billion | +27.06% |
| 2019 | $15.57 Billion | +26.72% |
| 2018 | $12.29 Billion | -28.40% |
| 2017 | $17.17 Billion | +11.95% |
| 2016 | $15.33 Billion | -28.30% |
| 2015 | $21.39 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of McKesson Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $101.38 Billion USD |
| MoneyControl | $101.38 Billion USD |
| MarketWatch | $101.38 Billion USD |
| marketcap.company | $101.38 Billion USD |
| Reuters | $101.38 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; d… Read more